Phase II study of a salvage regimen using cyclophosphamide, high‐dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B‐cell non‐Hodgkin's lymphoma
暂无分享,去创建一个
Y. Oki | Y. Kagami | M. Ogura | H. Taji | Y. Morishima | Kazuhito Yamamoto | Aya Oshiro | A. Kikuchi | H. Kato | A. Tsujimura